Biotechnology

Nanobiotechnology & Drug Delivery

Nanobiotechnology has emerged as a transformative field, integrating nanoscale materials with biological systems to revolutionize drug delivery and therapeutic interventions. By engineering nanoparticles, liposomes, dendrimers, and polymeric carriers, drugs can be precisely targeted to specific tissues, cells, or disease sites, enhancing therapeutic efficacy while minimizing off-target effects and systemic toxicity. Advances in stimuli-responsive and smart nanocarriers allow controlled, sustained, and triggered release of therapeutics, optimizing dosing regimens and patient compliance. Nanobiotechnology also enables the delivery of challenging molecules, including nucleic acids, peptides, and hydrophobic drugs, overcoming biological barriers such as the blood-brain barrier. Integration with imaging technologies facilitates real-time tracking and monitoring of drug distribution, supporting personalized medicine strategies. Research in this field spans oncology, cardiovascular diseases, infectious diseases, and regenerative medicine, highlighting broad clinical applications. With interdisciplinary collaboration among nanoscientists, biologists, and clinicians, nanobiotechnology-driven drug delivery continues to redefine precision therapeutics, improve patient outcomes, and advance the next generation of targeted treatments.